U.S. market Closed. Opens in 16 hours 50 minutes

PRTA | Prothena Corporation plc Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for PRTA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is weak.

Valuation (29%)

Company Industry
P/E Ratio (TTM) -6.28 -20.30
PEG Ratio (TTM) 0.04 -5.71
P/S Ratio (TTM) 6.21 50.88
P/B Ratio (TTM) 1.55 29.28
P/FCF Ratio (TTM) -5.35 -8.95
Price to 5YR AVG Earnings Ratio -9.11 -6.52
Price to 5YR AVG FCF Ratio -14.38 -14.78

Profitability (25%)

Company Industry
ROA (TTM) -22.15% -18.85%
ROE (TTM) -24.19% 25.35%
Net Profit Margin (TTM) -98.86% -827.80%
ROIC 5YR AVG 111.80% -26.10%

Growth (50%)

4QTR AVG 3YR AVG 5YR AVG
EPS -102.46% 54.05% -22.64%
Revenue 65,911.23% 7,801.44% 4,680.14%
Net Income -102.67% 55.76% -26.61%
Cash Flow -234.10% 25.40% -32.87%

Health (46%)

Company Industry
Current Ratio (TTM) 11.52 6.09
Quick Ratio (TTM) 11.52 5.87
D/E Ratio (TTM) N/A 1.00
Interest Coverage (TTM) -25.68 -9.57
Piotroski F-Score 2 4
Altman Z-Score 6.18 13.84
LTL to 5YR AVG FCF -0.19 0.07
Shares Outstanding Growth 5YR AVG 6.23% 44.11%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙